• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000年至2016年美国恶性胸膜间皮瘤的流行病学情况

Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.

作者信息

Thomas Akesh, Karakattu Sajin, Cagle Jeanette, Hoskere Girendra

机构信息

Internal Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, USA.

Pulmonary and Critical Care Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, USA.

出版信息

Cureus. 2021 Apr 21;13(4):e14605. doi: 10.7759/cureus.14605.

DOI:10.7759/cureus.14605
PMID:34040906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8139608/
Abstract

Introduction Pleural mesothelioma constitutes about 80% of all mesotheliomas. The peak incidence of malignant mesothelioma estimated using the cancer registries was in early 1990 to 2000 in the United States. The disease is primarily associated with asbestos exposure. The latency period between asbestos exposure and the development of malignant pleural mesothelioma (MPM) can range anywhere from 15 to 60 years. Asbestos exposure was peaked during the industrial revolution and World War II due to military and shipyard exposures. It is often difficult for the pathologist to distinguish different histological subtypes; due to the disease's rarity and the inadequate tissue sample obtained. There is no available data on the difference in epidemiology of different subtypes of MPM. Surveillance Epidemiology and End Results (SEER), cancer incidence data include population-based registries covering approximately 34.6% of the U.S. population. Here in our study, we analyze malignant pleural mesothelioma epidemiology in the United States, emphasizing different histological subtypes. Methods SEER data from 2000 to 2016 was used in our study. The primary site of cancer is selected as pleura, and malignant behavior only is selected as the filter. Data were analyzed using the SEER stat program. Overall epidemiology of MPM and epidemiology of epithelioid, fibrous, and biphasic histological subtypes were analyzed separately. We used annual percentage change (APC) to evaluate the trend in the epidemiology of MPM. Results summary A total of 11,857 cases of MPM were included in the primary cohort from the SEER 18 registry from 2000 to 2016. The total prevalence of MPM was highest in 2009 and was lowest in 2016. The APC in MPM incidence during this period is -2.0. After removing 5,989 cases with non-specified histology during the same period, the APC for each histological type is -0.7 for fibrous type, 1.8 for epithelioid type, and 2.9 for biphasic type. Out of 17 regional registries included in the study, the greatest statistically significant change in APC was seen in the Hawaiian registry -4.1. In contrast, the lowest statistically significant difference was seen in Seattle (Puget Sound) registry -1.7. The APC in the incidence of MPM among males during the study period was -2.4 while that of females was -0.9. The Iowa registry showed a statistically significant increase in APC of the epithelioid malignant mesothelioma with a statistically insignificant reduction in the overall MPM APC. Conclusion The overall incidence of MPM in the United States is declining, while the data showed an increase in the incidence of epithelioid and biphasic histological subtypes. The authors believe that these conflicting results can be attributed to improved histological diagnosis and improved biopsy techniques.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f72/8139608/25ea21c5d70b/cureus-0013-00000014605-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f72/8139608/ec4cc7ff848c/cureus-0013-00000014605-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f72/8139608/01ffdcc3d7ec/cureus-0013-00000014605-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f72/8139608/25ea21c5d70b/cureus-0013-00000014605-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f72/8139608/ec4cc7ff848c/cureus-0013-00000014605-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f72/8139608/01ffdcc3d7ec/cureus-0013-00000014605-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f72/8139608/25ea21c5d70b/cureus-0013-00000014605-i03.jpg

引言

胸膜间皮瘤约占所有间皮瘤的80%。根据癌症登记处的数据估计,美国恶性间皮瘤的发病高峰出现在1990年初至2000年。该疾病主要与接触石棉有关。石棉接触与恶性胸膜间皮瘤(MPM)发病之间的潜伏期可在15至60年的任何范围。由于军事和造船厂接触,石棉接触在工业革命和第二次世界大战期间达到高峰。病理学家通常很难区分不同的组织学亚型;这是由于该疾病罕见且获得的组织样本不足。目前尚无关于MPM不同亚型流行病学差异的可用数据。监测、流行病学和最终结果(SEER)癌症发病率数据包括覆盖约34.6%美国人口的基于人群的登记处。在我们的这项研究中,我们分析了美国恶性胸膜间皮瘤的流行病学,重点关注不同的组织学亚型。

方法

我们的研究使用了2000年至2016年的SEER数据。癌症的主要部位选择为胸膜,仅选择恶性行为作为筛选条件。使用SEER统计程序对数据进行分析。分别分析了MPM的总体流行病学以及上皮样、纤维样和双向组织学亚型的流行病学。我们使用年度百分比变化(APC)来评估MPM流行病学的趋势。

结果总结

2000年至2016年,SEER 18登记处的主要队列中总共纳入了11,857例MPM病例。MPM的总患病率在2009年最高,在2016年最低。在此期间MPM发病率的APC为-2.0。在去除同期5989例组织学未明确的病例后,纤维样类型的APC为-0.7,上皮样类型为1.8,双向类型为2.9。在纳入研究的17个地区登记处中,APC变化在统计学上最显著的是夏威夷登记处 -4.1。相比之下,在西雅图(普吉特海湾)登记处观察到统计学上最不显著的差异 -1.7。在研究期间,男性MPM发病率的APC为-2.4,而女性为-0.9。爱荷华登记处显示上皮样恶性间皮瘤的APC有统计学上显著的增加,而MPM总体APC有统计学上不显著的下降。

结论

美国MPM的总体发病率正在下降,而数据显示上皮样和双向组织学亚型的发病率有所增加。作者认为这些相互矛盾的结果可归因于组织学诊断的改善和活检技术的改进。

相似文献

1
Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.2000年至2016年美国恶性胸膜间皮瘤的流行病学情况
Cureus. 2021 Apr 21;13(4):e14605. doi: 10.7759/cureus.14605.
2
Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database.恶性胸膜间皮瘤的管理 - 第3部分:来自奥地利间皮瘤兴趣小组(AMIG)数据库的数据。
Wien Klin Wochenschr. 2016 Sep;128(17-18):627-34. doi: 10.1007/s00508-016-1037-2. Epub 2016 Jul 25.
3
Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.台湾即将出现与石棉相关的恶性胸膜间皮瘤流行:对未来 30 年发病率的预测。
J Formos Med Assoc. 2019 Jan;118(1 Pt 3):463-470. doi: 10.1016/j.jfma.2018.07.013. Epub 2018 Jul 31.
4
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.恶性胸膜和腹膜间皮瘤的发病率、治疗和生存情况:一项基于人群的研究。
Thorax. 2022 Dec;77(12):1260-1267. doi: 10.1136/thoraxjnl-2021-217709. Epub 2022 Feb 11.
5
Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.1994-2009 年爱尔兰共和国恶性胸膜间皮瘤的发病和生存情况。
Cancer Epidemiol. 2014 Feb;38(1):35-41. doi: 10.1016/j.canep.2013.12.002. Epub 2014 Jan 4.
6
Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan.石棉工厂中恶性胸膜间皮瘤的聚集:一项 29 年随访研究中的亚组分析,以确定台湾的高危行业。
BMJ Open. 2018 Dec 9;8(12):e021063. doi: 10.1136/bmjopen-2017-021063.
7
Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results-Medicare data.老年晚期恶性胸膜间皮瘤患者的治疗模式和结局:监测、流行病学和最终结果-医疗保险数据的分析。
Cancer Rep (Hoboken). 2022 Sep;5(9):e1568. doi: 10.1002/cnr2.1568. Epub 2021 Oct 26.
8
A Rare Case of Malignant Pleural Mesothelioma in a Young Healthy Male Without Asbestos Exposure.一名无石棉接触史的年轻健康男性患恶性胸膜间皮瘤的罕见病例。
Cureus. 2021 Aug 15;13(8):e17199. doi: 10.7759/cureus.17199. eCollection 2021 Aug.
9
Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009.1972 - 2009年新南威尔士州恶性胸膜和腹膜间皮瘤的发病率、死亡率及生存率模式
Aust N Z J Public Health. 2016 Jun;40(3):255-62. doi: 10.1111/1753-6405.12503. Epub 2015 Dec 29.
10
Malignant mesothelioma--German mesothelioma register 1987-1999.恶性间皮瘤——德国间皮瘤登记处1987 - 1999年数据
Int Arch Occup Environ Health. 2001 Aug;74(6):383-95. doi: 10.1007/s004200100240.

引用本文的文献

1
Trends in Mesothelioma Mortality in the United States Between 1999 and 2020.1999年至2020年美国间皮瘤死亡率趋势
JTO Clin Res Rep. 2025 Feb 11;6(5):100804. doi: 10.1016/j.jtocrr.2025.100804. eCollection 2025 May.
2
Asbestos ban policies and mesothelioma mortality in Greece.希腊的石棉禁令政策与间皮瘤死亡率
BMC Public Health. 2024 Apr 26;24(1):1177. doi: 10.1186/s12889-024-18030-x.
3
Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.恶性间皮瘤中与预后和免疫浸润相关的可变剪接的系统表征

本文引用的文献

1
Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.恶性胸膜间皮瘤组织病理学亚型的可重复性。
Arch Pathol Lab Med. 2018 Jun;142(6):747-752. doi: 10.5858/arpa.2017-0295-OA. Epub 2018 Mar 6.
2
Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma.黏液样变型上皮样胸膜间皮瘤定义了一个预后良好的组群:191例胸膜恶性间皮瘤患者的分析
J Clin Pathol. 2017 Feb;70(2):179-182. doi: 10.1136/jclinpath-2016-203993. Epub 2016 Oct 18.
3
Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States.
BMC Cancer. 2021 Jul 22;21(1):848. doi: 10.1186/s12885-021-08548-3.
石棉暴露所致间皮瘤:美国的流行病学模式及影响
J Toxicol Environ Health B Crit Rev. 2016;19(5-6):250-265. doi: 10.1080/10937404.2016.1195323.
4
Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.恶性胸膜间皮瘤首次诊断的病理报告:基于人群的方法。
Pathol Res Pract. 2016 Oct;212(10):886-892. doi: 10.1016/j.prp.2016.07.010. Epub 2016 Jul 22.
5
The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.2015 年世界卫生组织胸膜肿瘤分类:相较于 2004 年分类的进展。
J Thorac Oncol. 2016 Feb;11(2):142-54. doi: 10.1016/j.jtho.2015.11.005.
6
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.间皮瘤组织学亚型对监测、流行病学和最终结果数据库中预后的影响。
J Surg Res. 2015 Jun 1;196(1):23-32. doi: 10.1016/j.jss.2015.01.043. Epub 2015 Jan 29.
7
Arsenic, metals, fibres, and dusts.砷、金属、纤维和粉尘。
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt C):11-465.
8
Initial analysis of the international association for the study of lung cancer mesothelioma database.国际肺癌研究协会间皮瘤数据库的初步分析。
J Thorac Oncol. 2012 Nov;7(11):1631-9. doi: 10.1097/JTO.0b013e31826915f1.
9
Pleomorphic mesothelioma: report of 10 cases.多形性间皮瘤:10 例报告。
Mod Pathol. 2012 Jul;25(7):1011-22. doi: 10.1038/modpathol.2012.39. Epub 2012 Mar 2.
10
Asbestos and lung disease.石棉与肺部疾病。
Am J Respir Cell Mol Biol. 2010 Feb;42(2):131-2. doi: 10.1165/rcmb.2010-2002ED.